Annals of Coloproctology

Volume 35(5); October 2019

Editorials

Factors Affecting Surgical Treatment With Infliximab Therapy in Perianal Fistula With Crohn Disease: Jong Lyul Lee; Ann Coloproctol. 2019;35(5):225-226. Published online October 31, 2019; DOI: https://doi.org/10.3393/ac.2019.10.11

3,023 View
83 Download
2 Web of Science
2 Citations

PDF

Citations

Citations to this article as recorded by

Efficacy of stem cells therapy for Crohn’s fistula: a meta-analysis and systematic review
Yantian Cao, Qi Su, Bangjie Zhang, Fangfang Shen, Shaoshan Li
Stem Cell Research & Therapy.2021;[Epub] CrossRef
Treatment Strategy for Perianal Fistulas in Crohn Disease Patients: The Surgeon’s Point of View
Jong Lyul Lee, Yong Sik Yoon, Chang Sik Yu
Annals of Coloproctology.2021; 37(1): 5. CrossRef

Tailgut Cyst, Report of 24 Cases Single Center Experience: Han Deok Kwak, Chang Hyun Kim; Ann Coloproctol. 2019;35(5):227-228. Published online October 31, 2019; DOI: https://doi.org/10.3393/ac.2019.10.14

2,937 View
88 Download
1 Web of Science
1 Citations

PDF

Citations

Citations to this article as recorded by

Minimally invasive approach for retrorectal tumors above and below S3: a multicentric tertiary center retrospective study (MiaRT study)
T. Bardol, R. Souche, C. Druet, M. M. Bertrand, C. Ferrandis, M. Prudhomme, F. Borie, J.-M. Fabre
Techniques in Coloproctology.2024;[Epub] CrossRef

Review

Reconsideration of the Safety of Laparoscopic Rectal Surgery for Cancer: Gyung Mo Son, Bong-Hyeon Kye, Min Ki Kim, Jun-Gi Kim; Ann Coloproctol. 2019;35(5):229-237. Published online October 31, 2019; DOI: https://doi.org/10.3393/ac.2019.10.16

3,967 View
115 Download
4 Web of Science
4 Citations

Abstract PDF

The oncological outcomes of laparoscopic rectal cancer surgery were evaluated in recent multicenter randomized clinical trials (RCTs). The MRC-CLASSIC, COLOR II, and COREAN trials found no differences in local recurrence or diseasefree survival rate between laparoscopic and open surgery. However, the noninferiority of laparoscopic surgery with respect to open surgery for rectal cancer was not established on statistical analysis in the ACOSOG Z6051 and the ALaCaRT trials. Quality of total mesorectal excision (TME) is one of the most important prognostic factors. Incomplete TME had unfavorable oncologic outcomes compared to complete TME. Although TME quality can be clearly identified on pathologic evaluation, there is controversy regarding the acceptable range of oncologically safe TME for laparoscopic surgery. It is not certain whether near-complete TME has an unfavorable oncologic impact and whether laparoscopic surgery with near-complete TME is an oncological threat. Therefore, the surgical community will be interested in the long-term outcomes and meta-analyses of ongoing large-scale RCTs. Laparoscopic rectal cancer surgery has been steadily improving its safety for oncology surgery, which has been reported consistently in various multicenter RCTs. To improve surgical quality, colorectal surgeons should choose the most appropriate surgical technique, including laparoscopic surgery.

Citations

Citations to this article as recorded by

Operative and Survival Outcomes of Robotic-Assisted Surgery for Colorectal Cancer in Elderly and Very Elderly Patients: A Study in a Tertiary Hospital in South Korea
Hugo Cuellar-Gomez, Siti Mayuha Rusli, María Esther Ocharan-Hernández, Tae-Hoon Lee, Guglielmo Niccolò Piozzi, Seon-Hahn Kim, Cruz Vargas-De-León, Yazhou He
Journal of Oncology.2022; 2022: 1. CrossRef
Evidenz in der minimal-invasiven onkologischen Chirurgie des Kolons und des Rektums
Carolin Kastner, Joachim Reibetanz, Christoph-Thomas Germer, Armin Wiegering
Der Chirurg.2021; 92(4): 334. CrossRef
The Safety and Feasibility of Laparoscopic Surgery for Very Low Rectal Cancer: A Retrospective Analysis Based on a Single Center’s Experience
Hyuk-Jun Chung, Jun-Gi Kim, Hyung-Jin Kim, Hyeon-Min Cho, Bong-Hyeon Kye
Biomedicines.2021; 9(11): 1720. CrossRef
Reoperative laparoscopic rectal surgery: Another potential tool for the expert’s toolbox
Marc D. Basson
The American Journal of Surgery.2020; 219(6): 894. CrossRef

Original Articles

The Ligation of Intersphincteric Fistula Tract Technique: A Preliminary Experience: Pasquale Cianci, Nicola Tartaglia, Alberto Fersini, Libero Luca Giambavicchio, Vincenzo Neri, Antonio Ambrosi; Ann Coloproctol. 2019;35(5):238-241. Published online October 31, 2019; DOI: https://doi.org/10.3393/ac.2018.08.16.1

5,783 View
141 Download
4 Web of Science
6 Citations

Abstract PDF

Purpose
Surgery is the only treatment for anal fistula. Many surgical techniques have been described. The aim of this study was to communicate the authors’ preliminary experience in the use of a recently proposed, simplified technique.
Methods
This was a prospective study of 28 patients admitted from January 13, 2016 through July 20, 2017. Patients were managed with the ligation of intersphincteric fistula tract (LIFT) technique and results were observed and documented, including recurrence rate, incontinence rate, and other postoperative complications.
Results
A total of 28 patients were studied. The mean operation time was 31 minutes (range, 23–44 minutes), and there were no intra- and postoperative complications. The overall complete healing rate was 85.7%, and the recurrence rate was 14.2%. Follow-up was conducted at 1, 3, and 6 months.
Conclusion
Many surgical techniques have been described for the treatment of anal fistula. The correct choice of surgical technique out of available procedures is the most important factor for proper treatment and reducing the risk of recurrence or incontinence. In the authors’ experience, the LIFT technique is simple and easy to learn, and is a good choice for the treatment of simple anal fistula; however, a tailored surgery remains the gold standard for this condition.

Citations

Citations to this article as recorded by

Evaluation of the outcomes of fistulotomy with primary sphincter reconstruction in the management of high trans-sphincteric fistula and supra-sphincteric fistula-in-ano
Basma Hussein Abdelaziz Hassan, Philobater Bahgat Adly Awad, Mostafa Mohamed Abdelaziz, Mohammed Hossam, Mohamed Ali Mohamed Nada
Die Chirurgie.2024;[Epub] CrossRef
Ligation of Intersphincteric Fistula Tract (LIFT) for the Treatment of Anal Fistula: A Prospective Observational Study
L.A. Hidalgo-Grau, N. Ruiz-Edo, O. Estrada-Ferrer, E.M. García-Torralbo, M. del Bas-Rubia, P. Clos-Ferrero, E. Bombuy-Giménez
Journal of Coloproctology.2023; 43(01): 024. CrossRef
Surgical treatment of anal fistula
A. Ya. Ilkanich, V. V. Darwin, E. A. Krasnov, F. Sh. Aliyev, K. Z. Zubailov
Сибирский научный медицинский журнал.2023; 43(5): 74. CrossRef
Advancing standard techniques for treatment of perianal fistula; when tissue engineering meets seton
Hojjatollah Nazari, Zahra Ebrahim Soltani, Reza Akbari Asbagh, Amirsina Sharifi, Abolfazl Badripour, Asieh Heirani Tabasi, Majid Ebrahimi Warkiani, Mohammad Reza Keramati, Behnam Behboodi, Mohammad Sadegh Fazeli, Amir Keshvari, Mojgan Rahimi, Seyed Mohsen
Health Sciences Review.2022; 3: 100026. CrossRef
Efficacy and safety of ligation of intersphincteric fistula tract in the treatment of anal fistula
Jiaji Zhang, Xilu Hao, Yican Zhu, Ronggang Luan
Medicine.2021; 100(4): e23700. CrossRef
Efficacy and safety of an innovatively modified cutting seton technique for the treatment of high anal fistula
Jie Jiang, Yang Zhang, Xufeng Ding, Naijin Zhang, Lijiang Ji
Medicine.2021; 100(5): e24442. CrossRef

Efficacy and Feasibility of Adding Induction Chemotherapy to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Phase II Clinical Trial: Hamid Nasrolahi, Sepideh Mirzaei, Mohammad Mohammadianpanah, Ali Mohammad Bananzadeh, Maral Mokhtari, Mohammad Reza Sasani, Ahmad Mosalaei, Shapour Omidvari, Mansour Ansari, Niloofar Ahmadloo, Seyed Hasan Hamedi, Nezhat Khanjani; Ann Coloproctol. 2019;35(5):242-248. Published online October 31, 2019; DOI: https://doi.org/10.3393/ac.2018.09.06

3,967 View
86 Download
5 Web of Science
5 Citations

Abstract PDF

Purpose
Currently, neoadjuvant chemoradiation (CRT) followed by total mesorectal resection is considered the standard of care for treating locally advanced rectal cancer. This study aimed to investigate the efficacy and feasibility of adding induction chemotherapy to neoadjuvant CRT in locally advanced rectal cancer.
Methods
This phase-II clinical trial included 54 patients with newly diagnosed, locally advanced (clinical T3–4 and/or N1–2, M0) rectal cancer. All patients were treated with 3 cycles of preoperative chemotherapy using the XELOX (capecitabine + oxaliplatin) regimen before and after a concurrent standard long course of CRT (45–50.4 Gy) followed by standard radical surgery. Pathologic complete response (PCR) rate and toxicity were the primary and secondary endpoints, respectively.
Results
The study participants included 37 males and 17 females, with a median age of 59 years (range, 20–80 years). Twenty-nine patients (54%) had clinical stage-II disease, and 25 patients (46%) had clinical stage-III disease. Larger tumor size (P = 0.006) and distal rectal location (P = 0.009) showed lower PCR compared to smaller tumor size and upper rectal location. Pathologic examinations showed significant tumor regression (6.1 ± 2.7 cm vs. 1.9 ± 1.8 cm, P < 0.001) with 10 PCRs (18.5%) compared to before the intervention. The surgical margin was free of cancer in 52 patients (96.3%). Treatment-related toxicities were easily tolerated, and all patients completed their planned treatment without interruption. Grade III and IV toxicities were infrequent.
Conclusion
The addition of induction chemotherapy to neoadjuvant CRT is an effective and well-tolerated treatment approach in patients with rectal cancer.

Citations

Citations to this article as recorded by

Nanomedicine integrating the lipidic derivative of 5-fluorouracil, miriplatin and PD-L1 siRNA for enhancing tumor therapy
An Lu, Yuhao Guo, Yi Yan, Lin Zhai, Xiangyu Wang, Weiran Cao, Zijie Li, Zhixia Zhao, Yujie Shi, Yuanjun Zhu, Xiaoyan Liu, Huining He, Zhiyu Wang, Jian-Cheng Wang
Chinese Chemical Letters.2024; 35(6): 108928. CrossRef
Watch and wait strategies for rectal cancer: A systematic review
In Ja Park
Precision and Future Medicine.2022; 6(2): 91. CrossRef
Intensified Total Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer: A Phase II Trial
F. De Felice, G. D'Ambrosio, F. Iafrate, A. Gelibter, F.M. Magliocca, D. Musio, S. Caponetto, G. Casella, I. Clementi, A. Picchetto, G. Sirgiovani, M. Parisi, C. Orciuoli, G. Torrese, G. De Toma, V. Tombolini, E. Cortesi
Clinical Oncology.2021; 33(12): 788. CrossRef
Efficacy and safety of sequential neoadjuvant chemotherapy and short-course radiation therapy followed by delayed surgery in locally advanced rectal cancer: a single-arm phase II clinical trial with subgroup analysis between the older and young patients
Alimohammad Bananzadeh, Ali Akbar Hafezi, NamPhong Nguyen, Shapour Omidvari, Ahmad Mosalaei, Niloofar Ahmadloo, Mansour Ansari, Mohammad Mohammadianpanah
Radiation Oncology Journal.2021; 39(4): 270. CrossRef
Induction Chemotherapy in Patients With Anal Canal Cancer: A Pilot Study
Francesca De Felice, Daniela Musio, Vincenzo Tombolini
Clinical Colorectal Cancer.2020; 19(3): e137. CrossRef

Evaluation of a Seton Procedure Combined With Infliximab Therapy (Early vs. Late) in Perianal Fistula With Crohn Disease: Myunghoon Jeon, Kihwan Song, Jail Koo, Sohyun Kim; Ann Coloproctol. 2019;35(5):249-253. Published online October 31, 2019; DOI: https://doi.org/10.3393/ac.2018.11.23.1

3,678 View
122 Download
11 Web of Science
11 Citations

Abstract PDF

Purpose
We assessed the clinical outcomes of a seton procedure combined with early versus late institution of infliximab (IFX) therapy.
Methods
This retrospective study comprised 76 patients who underwent surgery for perianal fistula associated with Crohn disease between January 2014 and November 2017. All patients underwent loose seton drainage combined with IFX therapy. Patients categorized as the early group (EG, 49 patients) received IFX therapy within 30 days of completion of the seton procedure. Patients categorized as the late group (LG, 27 patients) received IFX therapy >30 days after the seton procedure. IFX therapy was administered as induction and maintenance therapy.
Results
There were no statistically significant intergroup differences in clinical characteristics of the patients. The mean follow-up was 21.0 ± 11.6 months in the EG and 34.5 ± 18.4 months in the LG (P = 0.001). The mean interval between seton procedure and IFX induction therapy was 12.2 days in the EG and 250.2 days in the LG (P = 0.002). Complete remission was observed in 32 patients (65.3%) in the EG and 17 patients (63.0%) in the LG (P = 0.844). Fistula recurrence was observed in 6 patients (7.9%). All recurrences occurred in a previous perianal fistula tract.
Conclusion
Patients showed a good response to a seton procedure combined with IFX therapy regardless of the time of initiation of IFX therapy.

Citations

Citations to this article as recorded by

Management of Perianal Fistulizing Crohn’s Disease
Arshdeep Singh, Vandana Midha, Gursimran Singh Kochhar, Bo Shen, Ajit Sood
Inflammatory Bowel Diseases.2024; 30(9): 1579. CrossRef
The use of core descriptors from the ENiGMA code study in recent literature: a systematic review
Saher‐Zahra Khan, Andrea Arline, Kate M. Williams, Matthew J. Lee, Emily Steinhagen, Sharon L. Stein
Colorectal Disease.2024; 26(3): 428. CrossRef
Impact of Seton Use on Clinical, Patient-Reported, and Healthcare Resource Utilization Outcomes in Complex Crohn’s Perianal Fistulas: A Systematic Literature Review
Ian White, Chitra Karki, Parnia Geransar, Lilia Leisle, Sophia Junker, Phillip Fleshner
Inflammatory Bowel Diseases.2024;[Epub] CrossRef
The Optimal Management of Fistulizing Crohn’s Disease: Evidence beyond Randomized Clinical Trials
Panu Wetwittayakhlang, Alex Al Khoury, Gustavo Drügg Hahn, Peter Laszlo Lakatos
Journal of Clinical Medicine.2022; 11(11): 3045. CrossRef
The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Anorectal Abscess, Fistula-in-Ano, and Rectovaginal Fistula
Wolfgang B. Gaertner, Pamela L. Burgess, Jennifer S. Davids, Amy L. Lightner, Benjamin D. Shogan, Mark Y. Sun, Scott R. Steele, Ian M. Paquette, Daniel L. Feingold
Diseases of the Colon & Rectum.2022; 65(8): 964. CrossRef
Management of perianal fistula in inflammatory bowel disease: identification of prognostic factors associated with surgery
Sara Gortázar de Las Casas, Mario Alvarez-Gallego, Jose Antonio Gazo Martínez, Natalia González Alcolea, Cristina Barragán Serrano, Aitor Urbieta Jiménez, María Dolores Martín Arranz, Jose Luis Marijuan Martín, Isabel Pascual Migueláñez
Langenbeck's Archives of Surgery.2021; 406(4): 1181. CrossRef
Treatment Strategy for Perianal Fistulas in Crohn Disease Patients: The Surgeon’s Point of View
Jong Lyul Lee, Yong Sik Yoon, Chang Sik Yu
Annals of Coloproctology.2021; 37(1): 5. CrossRef
Multidisciplinary management of perianal Crohn's disease
Suha Abushamma, David H. Ballard, Radhika K. Smith, Parakkal Deepak
Current Opinion in Gastroenterology.2021; 37(4): 295. CrossRef
Approach to medical therapy in perianal Crohn’s disease
Abhinav Vasudevan, David H Bruining, Edward V Loftus, William Faubion, Eric C Ehman, Laura Raffals
World Journal of Gastroenterology.2021; 27(25): 3693. CrossRef
Infliximab

Reactions Weekly.2020; 1785(1): 284. CrossRef
Mesenchymal stem cells in perianal Crohn’s disease
H. Guadalajara, M. García-Arranz, M. Dolores Herreros, K. Borycka-Kiciak, A. L. Lightner, D. García-Olmo
Techniques in Coloproctology.2020; 24(8): 883. CrossRef

Indication for and Effect of Adjuvant Chemotherapy for Stage IIa (T3N0M0) Colon Cancer: Chul-Hyo Jeon, Min Ki Kim, In Kyu Lee; Ann Coloproctol. 2019;35(5):254-261. Published online October 31, 2019; DOI: https://doi.org/10.3393/ac.2018.12.04

3,914 View
92 Download
2 Web of Science
2 Citations

Abstract PDF

Purpose
The efficacy of adjuvant chemotherapy (AC) in stage IIa colon cancer is controversial. This study aimed to investigate the factors influencing survival in patients with stage IIa colon cancer, the role of AC, and the indications for AC utilization by surgical oncologists.
Methods
Between January 2004 and December 2010, 736 patients with stage IIa colon cancer underwent curative resection in 1 of 6 participating hospitals. Factors related to survival were identified and analyzed according to whether AC was administered or not. After high- and low-risk groups were identified, their respective results were analyzed.
Results
The 5-year overall survival (OS) of stage IIa colon cancer was 90.3%. With the exception of poorly differentiated histology, indications for AC did not include typical high-risk factors. The indications for AC were significantly younger patients, higher body mass index (BMI), lower American Society of Anesthesiologists (ASA) physical status classification, and higher histologic grade. BMI, preoperative carcinoembryonic antigen, and harvested lymph node (LN) count were significant factors for disease-free survival, while BMI and ASA physical status classification were significant factors for OS in the chemotherapy group. In the high-risk group, AC was associated with increased OS in univariate analysis. BMI and harvested LN count were statistically significant in multivariate analysis.
Conclusion
Surgical oncologists consider the patient’s condition and postoperative course rather than high-risk factors to determine use of AC. Regardless of AC use, both the extent of surgery and the patient’s subsequent status affected the survival rate in the high-risk group. None of the factors identified influenced survival rate in the low-risk group.

Citations

Citations to this article as recorded by

Use of ascitic CEA levels as a predictive value for distant metastasis in high-risk stage II and III colorectal cancer
Abdullah Al-Sawat, Jung Hoon Bea, Seung-Rim Han, Hyo Jin Lee, Mi Ran Yoon, Yoon Suk Lee, Do Sang Lee, Chul Seung Lee, In Kyu Lee
International Journal of Colorectal Disease.2022; 37(2): 365. CrossRef
Prognostic Factor and Survival Benefit of Adjuvant Chemotherapy in Stage IIA Colon Cancer
Mok-Won Lee, Jin-Su Kim, Ji-Yeon Kim, Kyung-ha Lee
Annals of Coloproctology.2021; 37(1): 35. CrossRef

Comparison of Delorme-Thiersch Operation Outcomes in Men and Women With Rectal Prolapse: Keehoon Hyun, Seo-Gue Yoon; Ann Coloproctol. 2019;35(5):262-267. Published online October 31, 2019; DOI: https://doi.org/10.3393/ac.2018.10.15.1

3,219 View
80 Download
4 Web of Science
5 Citations

Abstract PDF

Purpose
The laparoscopic rectopexy has become increasingly popular with verified stability, surgical route selection should be tailored to individual patient characteristics rather than operative risk. The perineal approach is useful in young male patients who need to preserve fertility. This study aimed to compare the characteristics of men and women who underwent Delorme-Thiersch procedures and analyze the postoperative outcomes of the perineal approach by sex.
Methods
We retrospectively reviewed the medical records of 293 patients who underwent Delorme-Thiersch operations in Seoul Song Do Colorectal Hospital between January 2011 and September 2017. Patient clinical characteristics and postoperative complications were analyzed by sex. We analyzed surgical outcomes with preoperative and 3-month postoperative incontinence questionnaires, constipation levels, and anal manometry.
Results
In this study, men with rectal prolapse were younger than women with the same condition. American Society of Anesthesiologists physical status classifications were higher in women and women had more L-spine X-ray and pudendal nerve terminal motor latency test abnormalities. Anorectal manometry pressures were higher in men. Men also had longer operation times and hospital stays and more postoperative complications (8 T ring infections, 6 patients with bleeding, 3 with strictures, 2 with severe pain, and 2 with rectal perforations). The recurrence rate was higher among women.
Conclusion
Men with rectal prolapse were younger, healthier, and had relatively better anorectal function than women. The Delorme-Thiersch operation in men promoted lower recurrence rates and was advantageous in preserving the fertility of young patients, but the incidence of complications was also higher in men. Adequate counseling and preparation for the possibility of complications are needed.

Citations

Citations to this article as recorded by

Assessment of Laparoscopic Posterior Mesh Rectopexy for Complete Rectal Prolapse: A Case Series with Review of Literature
Vishal Chawda, Abhijit Joshi
International Journal of Recent Surgical and Medical Sciences.2023; 09(01): 059. CrossRef
A comparative study on the surgical options for male rectal prolapse
Han Deok Kwak, Jun Seong Chung, Jae Kyun Ju
Journal of Minimal Access Surgery.2022; 18(3): 426. CrossRef
Clinical outcomes of surgical management for recurrent rectal prolapse: a multicenter retrospective study
Kwang Dae Hong, Keehoon Hyun, Jun Won Um, Seo-Gue Yoon, Do Yeon Hwang, Jaewon Shin, Dooseok Lee, Se-Jin Baek, Sanghee Kang, Byung Wook Min, Kyu Joo Park, Seung-Bum Ryoo, Heung-Kwon Oh, Min Hyun Kim, Choon Sik Chung, Yong Geul Joh
Annals of Surgical Treatment and Research.2022; 102(4): 234. CrossRef
Longer prolapsed rectum length increases recurrence risk after Delorme’s procedure
Taro Tanabe, Emi Yamaguchi, Takuya Nakada, Risa Nishio, Kinya Okamoto, Tetsuo Yamana
Annals of Coloproctology.2022; 38(4): 314. CrossRef
Perineal stapled prolapse resection in combination with Thiersch operation for relapsed rectal prolapse: a case report
Teppei Kamada, Hironori Ohdaira, Junji Takahashi, Yoshinobu Fuse, Wataru Kai, Keigo Nakashima, Yuichi Nakaseko, Norihiko Suzuki, Masashi Yoshida, Takeo Usui, Yutaka Suzuki
Surgical Case Reports.2021;[Epub] CrossRef

Single-center Experience of 24 Cases of Tailgut Cyst: Ahmad Sakr, Ho Seung Kim, Yoon Dae Han, Min Soo Cho, Hyuk Hur, Byung Soh Min, Kang Young Lee, Nam Kyu Kim; Ann Coloproctol. 2019;35(5):268-274. Published online October 31, 2019; DOI: https://doi.org/10.3393/ac.2018.12.18

8,105 View
260 Download
25 Web of Science
37 Citations

Abstract PDF

Purpose
Tailgut cysts are rare congenital or developmental lesions that arise from vestiges of the embryological hindgut. They are usually present in the presacral space. We report our single-center experience with managing tailgut cysts.
Methods
We conducted a retrospective analysis of 24 patients with tailgut cyst treated surgically at the Colorectal Surgery Department of Severance Hospital, Yonsei University, Seoul, South Korea, between 2007–2018.
Results
This study included 24 patients (18 females) with a median age of 51.5 years (range, 21–68 years). Ten cases were symptomatic and 14 were asymptomatic. Cysts were retrorectal in 21 patients. Cysts were below the coccyx level in 16 patients, opposite the coccyx in 6, and above the coccyx in 2. Cysts were supralevator in 5 patients, had a supra- and infralevator extension in 18 patients, and were infralevator in 1. Ten patients were managed using an anterior laparoscopic approach, 11 using a posterior approach, and 3 using a combined approach. Mean cyst size was 5.5 ± 2.7 cm. Postoperative complications were Clavien-Dindo (CD) classification grade II in 9 patients (37.5%) and CD grade III in 1 (4.2%). The posterior approach group showed the highest rate of complications (P = 0.021). Patients managed using a combined approach showed a larger cyst size (P < 0.001), longer operation times (P < 0.001), and a greater likelihood of tumor level above the coccyx (P = 0.002) compared to other approaches. The tumors of 2 male patients were malignant: 1 was a neuroendocrine tumor treated with radiotherapy, while the other was a closely followed adenocarcinoma. Median follow-up was 12 months (range, 1–66 months) with no recurrence.
Conclusion
Tailgut cysts are uncommon but can cause perineal or pelvic pain. Complete surgical excision via an appropriate approach according to tumor size, location, and correlation with adjacent pelvic floor muscles is the key treatment.

Citations

Citations to this article as recorded by

Trans‐abdominal single‐incision robotic surgery with the da Vinci SP® surgical system for 8 cases of retrorectal tumour
Ho Seung Kim, Bo‐Young Oh, Soon Sup Chung, Ryung‐Ah Lee, Gyoung Tae Noh
The International Journal of Medical Robotics and Computer Assisted Surgery.2024;[Epub] CrossRef
Three Cases of Anal Cystic Lesions in Our Hospital
Kaori Tanaka, Toshiharu Mori, Hideki Yamada, Hideki Mori
Nihon Daicho Komonbyo Gakkai Zasshi.2024; 77(4): 199. CrossRef
Diagnosis and treatment of retrorectal cystic hamartoma: clinical case
S. A. Zvezda, D. G. Dimitriadi, P. I. Tamrazov, A. V. Simonov, E. M. Frank, N. M. Fedorov, L. N. Komarova
Surgery and Oncology.2024; 14(1): 72. CrossRef
Presacral Tailgut Cyst
Shriya Haval, Divyansh Dwivedi, Prabhat Nichkaode
Annals of African Medicine.2024; 23(2): 237. CrossRef
A neuroendocrine tumor arising in a tailgut cyst: Case report and literature review
Wei Guo, Ming Deng, Qiongrong Chen
International Journal of Surgery Case Reports.2024; 120: 109912. CrossRef
Tailgut Cyst in a Child: A Case Report and Review of Literature
Ramendra Shukla, Jay Divyesh Patel, Sudhir B. Chandna, Urvish Parikh
African Journal of Paediatric Surgery.2024; 21(3): 184. CrossRef
Two Cases of Symptomatic Tailgut Cysts
Jan Wojciechowski, Tomasz Skołozdrzy, Piotr Wojtasik, Maciej Romanowski
Journal of Clinical Medicine.2024; 13(17): 5136. CrossRef
The management of retrorectal tumors – a single-center analysis of 21 cases and overview of the literature
K. Fechner, B. Bittorf, M. Langheinrich, K. Weber, M. Brunner, R. Grützmann, K. E. Matzel
Langenbeck's Archives of Surgery.2024;[Epub] CrossRef
Cystic lesions of the retrorectal space
Ian S Brown, Anna Sokolova, Christophe Rosty, Rondell P Graham
Histopathology.2023; 82(2): 232. CrossRef
Tailgut cyst mimicking second anal opening in an infant
Jay Lodhia, Mujaheed Suleman, Doreen Msemakweli, Joshua Tadayo, Patrick Amsi, David Msuya
Journal of Pediatric Surgery Case Reports.2023; 89: 102550. CrossRef
Surgery of presacral cysts: case series analysis and literature review
K. V. Stegnii, Zh. A. Rakhmonov, R. A. Goncharuk, M. A. Krekoten, E. R. Dvoinikova, E. V. Morova, M. О. Dmitriev
Pacific Medical Journal.2023; (2): 15. CrossRef
Surgical treatment of retrorectal tumors: a plea for a laparoscopic approach
Clara Galán, M. Pilar Hernández, M. Carmen Martínez, Anna Sánchez, Jesús Bollo, Eduardo Mª Targarona
Surgical Endoscopy.2023; 37(12): 9080. CrossRef
Robotic approach to remove four tailgut cyst cases in Brazil: a case series
Bruno Mirandola Bulisani, Luiz Guilherme Lisboa Gomes, Milena Arruda de Oliveira Leite, Ricardo Moreno, Murilo Rocha Rodrigues, Felipe Martin Bianco Rossi, Renato Barretto Ferreira da Silva, Luiz Carlos Benjamin do Carmo, Jaques Waisberg
einstein (São Paulo).2023;[Epub] CrossRef
Tumor neuroendocrino asociado con quiste intestinal: presentación de un caso
Lismary Ruiz Cabezas, Alicia Moreno Ontalba, Mario Díaz Delgado, Esther María Cidoncha Pérez, Alejandro Rubio Fernández, María Victoria González Ibáñez
Revista Española de Patología.2022; 55(4): 278. CrossRef
Risk of malignancy and outcomes of surgically resected presacral tailgut cysts: A current review of the Mayo Clinic experience
Sacha P. Broccard, Dorin T. Colibaseanu, Kevin T. Behm, Nitin Mishra, Peter Davis, Kristi L. Maimone, Kellie L. Mathis, Luca Stocchi, Eric J. Dozois, Amit Merchea
Colorectal Disease.2022; 24(4): 422. CrossRef
Squamous cell carcinoma in a retrorectal cystic hamartoma
Quintáns Ana Teijo, Valadés José Ignacio Martín , del Río Cristina Garrán , Rojo Irene López , Casado Oscar Alonso
Journal of Radiology and Oncology.2022; 6(1): 001. CrossRef
Retrorectal Tailgut Cyst: A Case Report
Neel Shah, Peter Edelstein
Cureus.2022;[Epub] CrossRef
A Case of Tailgut Cyst Treated with Laparoscopic Transabdominal and Transsacral Surgery
Naoki Kawahara, Yoshiyuki Suzuki, Yu Sakai, Shinji Maeshima, Takehiro Shimada
Nippon Daicho Komonbyo Gakkai Zasshi.2022; 75(4): 170. CrossRef
Promoting Laparoscopic Anterior Approach for a Very Low Presacral Primary Neuroendocrine Tumor Arising in a Tailgut Cyst
Maria Michela Di Nuzzo, Carlo De Werra, Mirella Pace, Raduan Ahmed Franca, Maria D’Armiento, Umberto Bracale, Ruggero Lionetti, Michele D’Ambra, Armando Calogero
Healthcare.2022; 10(5): 805. CrossRef
A Case of Dermoid Cyst in the Ischiorectal Fossa Resected by the Transperineal Approach
Susumu Daibo, Hirokazu Suwa, Seiya Sato, Koki Goto, Yusuke Suwa, Jun Watanabe
Nippon Daicho Komonbyo Gakkai Zasshi.2022; 75(5): 237. CrossRef
Perianal Tailgut Cyst: An Unusual Presentation
Rabia Arshad, Noor Khalid, Mubashir Rafique, Ruqia Mushtaq, Fakhar Munir Sial
Cureus.2022;[Epub] CrossRef
Squamous cell carcinoma arising in a tailgut cyst: role of radiotherapy
Diego Aldave, Ana Teijo, Claudia Abril, Laura Cerezo
BMJ Case Reports.2022; 15(9): e247985. CrossRef
Hamartoma quístico retrorrectal (tailgut cyst): reporte de un caso y revisión de la literatura
Juan Dario Puerta Diaz, Rodrigo Castaño Llano, Alfredo Enrique Martelo Román, Juan Esteban Puerta Botero
Revista colombiana de Gastroenterología.2022; 37(3): 316. CrossRef
Diagnostic, Therapeutic and Evolutionary Problems of Retro-Rectal Tumors (About 3 Cases)
Hajri Amal, Ahmed Elmi Abdirahim, Rachid Boufettal, Erguibi Driss, Saad Rifki El Jai, Farid Chehab
European Journal of Medical and Health Sciences.2022; 4(5): 13. CrossRef
Epidemiology, diagnostic approach and therapeutic management of tailgut cysts: A systematic review
Aikaterini Mastoraki, Ilias Giannakodimos, Karmia Panagiotou, Maximos Frountzas, Dimosthenis Chrysikos, Stylianos Kykalos, Georgios E. Theodoropoulos, Dimitrios Schizas
International Journal of Clinical Practice.2021;[Epub] CrossRef
Re: Malignant transformation of tailgut cysts is significantly higher than previously reported: Systematic review of cases in the literature
Tamara Glyn, Peter Sagar, Frank Frizelle
Colorectal Disease.2021; 23(11): 3027. CrossRef
Multicenter Analysis of Presacral Neuroendocrine Neoplasms—Clinicopathological Characterization and Treatment Outcomes of a Rare Disease
Sami Matrood, Leonidas Apostolidis, Jörg Schrader, Sebastian Krug, Harald Lahner, Annette Ramaswamy, Damiano Librizzi, Zoltan Kender, Anke Kröcher, Simon Kreutzfeldt, Thomas Matthias Gress, Anja Rinke
Frontiers in Endocrinology.2021;[Epub] CrossRef
Surgical Management of Retrorectal Tumors
Mathilde Aubert, Diane Mege, Yann Parc, Eric Rullier, Eddy Cotte, Guillaume Meurette, Philippe Zerbib, Bertrand Trilling, Bernard Lelong, Charles Sabbagh, Zaher Lakkis, Mehdi Ouaissi, Gil Lebreton, Philippe Rouanet, Gilles Manceau, Jean-Jacques Tuech, Gui
Annals of Surgery.2021; 274(5): 766. CrossRef
Isolated lumbar intradural tailgut cyst: A case report and review of the literature
Antonio Colamaria, Matteo Sacco, Giovanni Parbonetti, Maria Blagia, Francesco Carbone, Matteo de Notaris
Heliyon.2021; 7(10): e08223. CrossRef
Prerectal tailgut cyst presenting with constipation and pseudo-rectal prolapse. A rare case presentation
Allan Ngulube, Blessing Zambuko, Crispin O.M. Ntoto, Simbarashe Gift Mungazi, Derek Matsika
Human Pathology Reports.2021; 26: 300557. CrossRef
Anal Canal Duplication in an Adult Female—Case Report and Pathology Guiding
Tudor Mateescu, Cristi Tarta, Paul Stanciu, Alis Dema, Fulger Lazar
Medicina.2021; 57(11): 1205. CrossRef
“The Innate Tail”: An Unusual Cause of Rectal Bleeding in an Adult Male
Sujit Padmanabhan Nair, Sanjay Chandnani, Prasanta Debnath, Pravin M. Rathi, Parmeshwar Junare, Vinay Zanwar, Sangeeta Kini
GE - Portuguese Journal of Gastroenterology.2021; 28(5): 349. CrossRef
Robotic approach to large tailgut cyst with malignant transformation: A case report
Alessandra Marano, Maria Carmela Giuffrida, Chiara Peluso, Valentina Testa, Paolo Bosio, Felice Borghi
International Journal of Surgery Case Reports.2020; 77: S57. CrossRef
Laparoscopic resection of a neuroendocrine tumor that almost fully replaced tailgut cysts: a case report
Keita Kodera, Seiichiro Eto, Nei Fukasawa, Wataru Kai, Tomo Matsumoto, Tsuyoshi Hirabayashi, Hidejiro Kawahara, Nobuo Omura
Surgical Case Reports.2020;[Epub] CrossRef
Retrorectal tumors: Case report and review of literature
Giorgio La Greca, Giovanni Trombatore, Guido Basile, Pietro Conti
International Journal of Surgery Case Reports.2020; 77: 726. CrossRef
A Tailgut Cyst in the Ischiorectal Fossa—A Case Report—
Ryo INADA, Eri KURODA, Ayako WATANABE, Toshiaki TOSHIMA, Kazuhide OZAKI, Yuichi SHIBUYA, Manabu MATSUMOTO, Jun IWATA
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association).2020; 81(9): 1866. CrossRef
Tailgut Cyst, Report of 24 Cases Single Center Experience
Han Deok Kwak, Chang Hyun Kim
Annals of Coloproctology.2019; 35(5): 227. CrossRef

Sensitivity of Various Evaluating Modalities for Predicting a Pathologic Complete Response After Preoperative Chemoradiation Therapy for Locally Advanced Rectal Cancer: Sungwoo Jung, Anuj Parajuli, Chang Sik Yu, Seong Ho Park, Jong Seok Lee, Ah Young Kim, Jong Lyul Lee, Chan Wook Kim, Yong Sik Yoon, In Ja Park, Seok-Byung Lim, Jin Cheon Kim; Ann Coloproctol. 2019;35(5):275-281. Published online October 31, 2019; DOI: https://doi.org/10.3393/ac.2019.01.07

4,349 View
81 Download
3 Web of Science
3 Citations

Abstract PDF

Purpose
We investigated the sensitivity of various evaluating modalities in predicting a pathologic complete response (pCR) after preoperative chemoradiation therapy (PCRT) for locally advanced rectal cancer (LARC).
Methods
From a population of 2,247 LARC patients who underwent PCRT followed by surgery at Asan Medical Center, Seoul, Korea from January 2007 to June 2016, we retrospectively analyzed 313 patients (14.1%) who showed a pCR after surgery. Transrectal ultrasound (TRUS), high-resolution magnetic resonance imaging (MRI), abdominopelvic computed tomography (AP-CT), and endoscopy were performed within 2 weeks prior to surgery.
Results
Of the 313 patients analyzed, 256 (81.8%) had a pCR after radical surgery and 57 (18.2%) showed total regression after local excision. Preoperative TRUS, MRI, and AP-CT were performed in 283, 305, and 139 patients, respectively. Among these 3 groups, a prediction of a pCR of the primary tumor was made in 41 (14.5%), 51 (16.7%), and 27 patients (19.4%), respectively, before surgery. A prediction of a clinical N0 stage was made in 204 patients (88.3%) using TRUS, 130 (52.2%) using MRI, and 78 (65.5%) using AP-CT. Of the 211 patients who underwent endoscopy, 87 (41.2%) had a mention of clinical CR in their records. A prediction of a pathologic CR was made for 124 patients (39.6%) through at least one diagnostic modality.
Conclusion
The various evaluation methods for predicting a pCR after PCRT show a predictive sensitivity of 0.15–0.41 for primary tumors and 0.52–0.88 for lymph nodes. Endoscopy is a relatively superior modality for predicting the pCR of the primary tumor of LARC patients.

Citations

Citations to this article as recorded by

Comparison between Local Excision and Radical Resection for the Treatment of Rectal Cancer in ypT0-1 Patients: An Analysis of the Clinicopathological Factors and Survival Rates
Soo Young Oh, In Ja Park, Young IL Kim, Jong-Lyul Lee, Chan Wook Kim, Yong Sik Yoon, Seok-Byung Lim, Chang Sik Yu, Jin Cheon Kim
Cancers.2021; 13(19): 4823. CrossRef
Predicting Neoadjuvant Chemoradiotherapy Response in Locally Advanced Rectal Cancer Using Tumor-Infiltrating Lymphocytes Density
Yao Xu, Xiaoying Lou, Yanting Liang, Shenyan Zhang, Shangqing Yang, Qicong Chen, Zeyan Xu, Minning Zhao, Zhenhui Li, Ke Zhao, Zaiyi Liu
Journal of Inflammation Research.2021; Volume 14: 5891. CrossRef
A Nine-Gene Signature for Predicting the Response to Preoperative Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer
In Ja Park, Yun Suk Yu, Bilal Mustafa, Jin Young Park, Yong Bae Seo, Gun-Do Kim, Jinpyo Kim, Chang Min Kim, Hyun Deok Noh, Seung-Mo Hong, Yeon Wook Kim, Mi-Ju Kim, Adnan Ahmad Ansari, Luigi Buonaguro, Sung-Min Ahn, Chang-Sik Yu
Cancers.2020; 12(4): 800. CrossRef

Case Reports

Successful Conservative Management of Hepatic Portal Venous Gas due to Anastomosis Leakage After a Sigmoidectomy: Injae Hong, Seong Woo Hong, Yeo Gu Chang, Byungmo Lee, Woo Yong Lee, Haeng Jin Ohe, Young Ki Kim; Ann Coloproctol. 2019;35(5):282-284. Published online January 25, 2019; DOI: https://doi.org/10.3393/ac.2018.03.23.1

29,063 View
104 Download
4 Web of Science
4 Citations

Abstract PDF

In past decades, hepatic portal venous gas (HPVG) has rarely been reported, and the mortality rate has been very high. In most cases, surgical intervention was needed. Presently, abdominal computed tomography can be conveniently used to diagnose HPVG, which has various underlying causes and benign courses. We present the case of a patient with HPVG due to anastomosis leakage after a sigmoidectomy for diverticulitis; the patient was cured with conservative management.

Citations

Citations to this article as recorded by

Clinical features and management of 20 patients with hepatic portal venous gas
Yuan Zhang, Hai-Long Liu, Min Tang, Hui Wang, Hui-Hong Jiang, Mou-Bin Lin
Experimental and Therapeutic Medicine.2022;[Epub] CrossRef
Conservative treatment of hepatic portal venous gas resulting from non-occlusive mesenteric ischemia: a case report
Takuya Seike, Tusyoshi Suda, Naoki Oishi
Clinical Journal of Gastroenterology.2021; 14(5): 1404. CrossRef
Reply on “Successful Conservative Management of Hepatic Portal Venous Gas due to Anastomosis Leakage After a Sigmoidectomy”
Seongwoo Hong
Annals of Coloproctology.2020; 36(4): 212. CrossRef
Hepatic Portal Venous Gas and Anastomotic Leakage
Filippo Carannante, Gabriella Teresa Capolupo, Gianluca Mascianà, Marco Caricato
Annals of Coloproctology.2020; 36(4): 211. CrossRef

Inflammatory Myofibroblastic Tumor of the Retroperitoneum Including Chronic Granulomatous Inflammation Suggesting Tuberculosis: A Case Report: Younglim Kim, Ji Won Park, Sungwhan Kim, Kil-Yong Lee, Jeongmo Bae, Yoon Kyung Jeon, Ji Min Im, Seung-Bum Ryoo, Seung-Yong Jeong, Kyu Joo Park; Ann Coloproctol. 2019;35(5):285-288. Published online March 20, 2019; DOI: https://doi.org/10.3393/ac.2018.05.09

4,031 View
106 Download

Abstract PDF: An inflammatory myofibroblastic tumor (IMT) is a solid tumor of unknown etiology frequently affecting children and young adults and commonly affecting the lung or orbital region. We present a case involving a 41-year-old man who had an IMT combined with Mycobacterium tuberculosis infection in the retroperitoneum. He presented with only pain in the right lower abdomen without accompanying symptoms; a retroperitoneal mass was found on computed tomography. The tumor had invaded the end of the ileum and was attached to the omentum, so mass excision could not be performed. The tumor was completely excised surgically and had histological features diagnostic of an IMT. Histologic findings of the omentum were positive for Ziehl-Nielsen staining for acid-fast bacilli and for a positive polymerase chain reaction for M. tuberculosis. The patient had no apparent immune disorder. These findings made this case exceptional because IMTs, which are mostly due to atypical mycobacteria, have been found mainly in immunocompromised patients.

First
Prev
Page of 1
Next
Last

Previous issues